JPRN-jRCT2080221823未知2 期
A multicenter, randomized, double-blind, placebo-controlled, parallel-group study in subjects with irritable bowel syndrome with diarrhea
ONO PHARMACEUTICAL CO.,LTD.0 个研究点目标入组 240 人开始时间: 2012年6月13日最近更新:
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 <= 64age old（—）
- 性别
- All
入选标准
- •1. Subjects diagnosed with IBS-D based on the Rome III diagnostic criteria
排除标准
- •1. Presence or history of any of the organic gastrointestinal diseases
研究者
相似试验
进行中（未招募）
1 期
A Phase 3 study of efficacy and safety of remibrutinib in the treatment of chronic spontaneous urticaria in adults inadequately controlled by H1-antihistaminesEUCTR2021-000471-37-HUovartis Pharma AG450
进行中（未招募）
1 期
Efficacy, safety and tolerability of Serelaxin when added to standard therapy in acute heart failureEUCTR2013-001498-25-IEovartis Pharma Services AG6,800
已完成
不适用
HVTN 705/VAC89220HPX2008PACTR201705002290492Janssen Vaccines & Prevention B.V.2,600
进行中（未招募）
1 期
A study to evaluate the safety and efficacy of BYON5667 eye drops to reduce ocular toxicity in cancer patients treated with SYD985.EUCTR2020-005575-12-BEByondis B.V.205
进行中（未招募）
1 期
A study efficacy and safety of reparixin tablets in cancer related fatigue for breast cancer patients undergoing chemotherapyEUCTR2021-000382-32-DEDompé farmaceutici s.p.a.76